HSIC
HealthcareHenry Schein, Inc.
$78.54
+$1.72 (+2.24%)
Jan 5, 2026
Price History (1Y)
Analysis
Henry Schein, Inc. is a healthcare company operating in the medical distribution industry. The firm has a significant presence with a market capitalization of $9.52B and annual revenues of $12.94B, employing approximately 25,000 individuals. The financial health of Henry Schein appears to be stable, with gross margins at 31.2% and operating margins at 6.1%. Profitability is also evident through net income of $391M and EBITDA of $1.01B in the trailing twelve months. The company's balance sheet reveals a substantial amount of debt at $3.44B, but this is offset by cash reserves of $136M. Returns on equity and assets are 8.3% and 4.2%, respectively. Valuation metrics indicate that Henry Schein trades at a price-to-earnings ratio of 24.24 (TTM) and a forward P/E of 14.88, with revenue growth rates at 5.2% year-over-year. The company's debt-to-equity ratio is 70.22, and the current ratio stands at 1.40.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Henry Schein, Inc.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers. The company serves customers in dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Visit website →Key Statistics
- Market Cap
- $9.52B
- P/E Ratio
- 24.24
- 52-Week High
- $82.49
- 52-Week Low
- $60.56
- Avg Volume
- 1.41M
- Beta
- 0.88
Company Info
- Industry
- Medical Distribution
- Exchange
- NMS
- Country
- United States
- Employees
- 25,000